Status:
COMPLETED
Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Fresenius Medical Care Korea
Conditions:
Peritoneal Dialysis, Continuous Ambulatory
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Bioimpedance-guided fluid management in peritoneal dialysis patients may provide better protection of residual renal function over 1 year period, compared with management guided by clinical informatio...
Eligibility Criteria
Inclusion
- age bwten 20 and 75
- peritoneal dialysis \> 4 weeks duration
- written consent
- daily urine output \> 500 ml
Exclusion
- subjects who are contraindicated to the bioimpedance measurement (pacemaker insertion state, defibrillator state, amputee, prosthesis, metal implants)
- pregnant women
- subjects who are expected to discontinue peritoneal dialysis with one year
- mixed dialysis modality (peritoneal + hemodialysis)
- hypoalbuminemic subjects (serum albumin \< 3.3 g/dL)
- high blood pressure (\> 160/100 mmHg despite antihypertensive medications)
- severe heart failure (NYHA FC III, or IV)
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01887262
Start Date
July 1 2013
End Date
July 1 2016
Last Update
April 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital Clinical Trial Center
Seoul, South Korea, 110-744